Literature DB >> 22906534

Establishment of a model of atrial fibrillation associated with chronic kidney disease in rats and the role of oxidative stress.

Naoya Fukunaga1, Naohiko Takahashi, Satoshi Hagiwara, Osamu Kume, Akira Fukui, Yasushi Teshima, Tetsuji Shinohara, Tomoko Nawata, Masahide Hara, Takayuki Noguchi, Tetsunori Saikawa.   

Abstract

BACKGROUND: An animal model of atrial fibrillation (AF) associated with chronic kidney disease (CKD) has not been available.
OBJECTIVE: The purpose of this study was to test the validity of 5/6 nephrectomy (5.6Nx) as an appropriate model of AF associated with CKD and to investigate the role of oxidative stress.
METHODS: Male Sprague-Dawley rats were subjected to 5.6Nx. A novel derivative of lipoic acid, sodium zinc dihydrolipoylhistidinate (DHLHZn), was subcutaneously infused. Four weeks later, hearts were isolated.
RESULTS: We observed 5 main findings. (1) 5.6Nx induced renal dysfunction with elevation of systolic blood pressure and impaired glucose tolerance. (2) In the left atrium (LA), expressions of α-smooth muscle action and collagen type I, the compositional proteins of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, and malondialdehyde were increased by 5.6Nx, which was reversed by DHLHZn treatment. (3) In the LA, the tissue content of angiotensin II was elevated by 5.6Nx, which was also reversed by DHLHZn. (4) Masson trichrome staining revealed that heterogeneous LA interstitial fibrosis was induced by 5.6Nx, which was attenuated by DHLHZn. (5) In isolated perfused heart experiments, 5.6Nx caused slowing of interatrial conduction. In the hearts of rats of the 5.6Nxgroup, right atrial extrastimuli invariably induced AF (8/8 [100%]), which were suppressed by DHLHZn (3/8 [38%], P <.05).
CONCLUSION: We successfully established an appropriate model of AF associated with CKD in rats. Because the amount of NADPH oxidase was increased and the potent antioxidant agent DHLHZn was effective, oxidative stress may be involved in the pathogenesis of LA fibrosis and enhanced AF vulnerability in our model.
Copyright © 2012 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22906534     DOI: 10.1016/j.hrthm.2012.08.019

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  21 in total

1.  CHADS2 and CHA2DS2-VASc scores are independently associated with incident atrial fibrillation: the Catanzaro Atrial Fibrillation Project.

Authors:  Angela Sciacqua; Maria Perticone; Giovanni Tripepi; Eliezer J Tassone; Antonio Cimellaro; Deborah Mazzaferro; Giorgio Sesti; Francesco Perticone
Journal:  Intern Emerg Med       Date:  2015-05-05       Impact factor: 3.397

Review 2.  Uremic Toxins - Novel Arrhythmogenic Factor in Chronic Kidney Disease - Related Atrial Fibrillation.

Authors:  Shih-Yu Huang; Yi-Ann Chen; Shih-Ann Chen; Yi-Jen Chen; Yung-Kuo Lin
Journal:  Acta Cardiol Sin       Date:  2016-05       Impact factor: 2.672

3.  Effects of the dihydrolipoyl histidinate zinc complex against carbon tetrachloride-induced hepatic fibrosis in rats.

Authors:  Yuichiro Kawano; Masayuki Ohta; Yukio Iwashita; Yoko Komori; Masafumi Inomata; Seigo Kitano
Journal:  Surg Today       Date:  2014-09       Impact factor: 2.549

4.  Chronic kidney disease-induced atrial structural remodeling and atrial fibrillation: more studies on the pathological mechanism are encouraged.

Authors:  Huiliang Qiu; Chunlan Ji; Huanlin Wu; Chuan Zou
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-05-10       Impact factor: 3.000

5.  Syndecan-4 shedding is involved in the oxidative stress and inflammatory responses in left atrial tissue with valvular atrial fibrillation.

Authors:  Han Wu; Qing Zhou; Jun Xie; Guan-Nan Li; Qin-Hua Chen; Li-Na Kang; Biao Xu
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

6.  eGFR and Albuminuria in Relation to Risk of Incident Atrial Fibrillation: A Meta-Analysis of the Jackson Heart Study, the Multi-Ethnic Study of Atherosclerosis, and the Cardiovascular Health Study.

Authors:  Nisha Bansal; Leila R Zelnick; Alvaro Alonso; Emelia J Benjamin; Ian H de Boer; Rajat Deo; Ronit Katz; Bryan Kestenbaum; Jehu Mathew; Cassianne Robinson-Cohen; Mark J Sarnak; Michael G Shlipak; Nona Sotoodehnia; Bessie Young; Susan R Heckbert
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-10       Impact factor: 8.237

7.  Oxidative Stress Biomarkers and Incidence of Postoperative Atrial Fibrillation in the Omega-3 Fatty Acids for Prevention of Postoperative Atrial Fibrillation (OPERA) Trial.

Authors:  Jason H Y Wu; Roberto Marchioli; Maria G Silletta; Serge Masson; Frank W Sellke; Peter Libby; Ginger L Milne; Nancy J Brown; Federico Lombardi; Ralph J Damiano; Joann Marsala; Mauro Rinaldi; Alberto Domenech; Caterina Simon; Luigi Tavazzi; Dariush Mozaffarian
Journal:  J Am Heart Assoc       Date:  2015-05-20       Impact factor: 5.501

8.  Renal denervation suppresses atrial fibrillation in a model of renal impairment.

Authors:  Zhuo Liang; Xiang-min Shi; Li-feng Liu; Xin-pei Chen; Zhao-liang Shan; Kun Lin; Jian Li; Fu-kun Chen; Yan-guang Li; Hong-Yang Guo; Yu-tang Wang
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

9.  Association of circulating cardiac biomarkers with electrocardiographic abnormalities in chronic kidney disease.

Authors:  Alexander J Kula; Ronit Katz; Leila R Zelnick; Elsayed Soliman; Alan Go; Michael Shlipak; Rajat Deo; Bonnie Ky; Ian DeBoer; Amanda Anderson; Rob Christenson; Stephen L Seliger; Chris Defilippi; Harold I Feldman; Myles Wolf; John Kusek; Tariq Shafi; Jiang He; Nisha Bansal
Journal:  Nephrol Dial Transplant       Date:  2021-12-02       Impact factor: 5.992

10.  Cardiac melanocytes influence atrial reactive oxygen species involved with electrical and structural remodeling in mice.

Authors:  Hayoung Hwang; Fang Liu; Nataliya B Petrenko; Jianhe Huang; Kurt J Schillinger; Vickas V Patel
Journal:  Physiol Rep       Date:  2015-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.